A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID. - M Bader S; Calleja DJ; Devine SM; Kuchel NW; Lu BGC; Wu X; Birkinshaw RW; Bhandari R; Loi K; Volpe R; Khakham Y; Au AE; et al. (Nature communications, 2025)